General Information of the Compound
Compound ID
CP0373186
Compound Name
N-benzyl-2-(3-phenyl-2-piperidin-1-yl-4H-quinazolin-4-yl)acetamide
    Show/Hide
Synonyms
BDBM50148175
CHEMBL114695
KYS-05001
N-Benzyl-2-(3-phenyl-2-piperidin-1-yl-3,4-dihydro-quinazolin-4-yl)-acetamide
SCHEMBL14417320
    Show/Hide
Structure
Formula
C28H30N4O
Molecular Weight
438.575
Canonical SMILES
O=C(CC1N(C(=Nc2ccccc12)N1CCCCC1)c1ccccc1)NCc1ccccc1
    Show/Hide
InChI
InChI=1S/C28H30N4O/c33-27(29-21-22-12-4-1-5-13-22)20-26-24-16-8-9-17-25(24)30-28(31-18-10-3-11-19-31)32(26)23-14-6-2-7-15-23/h1-2,4-9,12-17,26H,3,10-11,18-21H2,(H,29,33)
    Show/Hide
InChIKey
IROXHJVGJHVBSD-UHFFFAOYSA-N
Physicochemical Property
logP
5.4278
Rotatable Bonds
5
Heavy Atom Count
33
Polar Areas
47.94
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9980573
SID: 14958568
ChEMBL ID
CHEMBL114695
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03095, Voltage-dependent T-type calcium channel subunit alpha-1G
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 900 nM
   TI
   LI
   LO
   TS
2
IC50 = 1160 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( KYS-05001 )
Drug Name KYS-05001
Target(s)
Voltage-gated calcium channel alpha Cav3.2 (CACNA1H)
Inhibitor
Voltage-gated calcium channel alpha Cav3.1 (CACNA1G)
Inhibitor